PMC:7247521 / 0-1140
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1 | 19-34 | Disease | denotes | COVID-19 injury | MESH:C000657245 |
3 | 221-229 | Disease | denotes | COVID-19 | MESH:C000657245 |
5 | 356-365 | Species | denotes | 2019-nCov | Tax:2697049 |
7 | 428-436 | Disease | denotes | COVID-19 | MESH:C000657245 |
28 | 978-982 | Gene | denotes | PPAR | Gene:5465 |
33 | 863-877 | Gene | denotes | oxidoreductase | Gene:8630 |
35 | 811-814 | Chemical | denotes | FUs | |
36 | 888-893 | Chemical | denotes | lipid | MESH:D008055 |
37 | 956-963 | Chemical | denotes | steroid | MESH:D013256 |
39 | 544-552 | Disease | denotes | COVID-19 | MESH:C000657245 |
40 | 1042-1054 | Disease | denotes | TTD diseases | MESH:D003141 |
41 | 1064-1085 | Disease | denotes | inflammatory diseases | MESH:D007249 |
42 | 1087-1093 | Disease | denotes | asthma | MESH:D001249 |
43 | 1095-1132 | Disease | denotes | chronic obstructive pulmonary Disease | MESH:D029424 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 19-27 | SP_7 | denotes | COVID-19 |
T2 | 71-76 | NCBITaxon:10239 | denotes | viral |
T3 | 109-118 | GO:0008152 | denotes | metabolic |
T4 | 221-229 | SP_7 | denotes | COVID-19 |
T5 | 239-244 | NCBITaxon:10239 | denotes | viral |
T6 | 250-263 | CHEBI:67079;CHEBI:67079 | denotes | -inflammatory |
T7 | 268-277 | GO:0008152 | denotes | metabolic |
T8 | 356-365 | SP_7 | denotes | 2019-nCov |
T9 | 428-436 | SP_7 | denotes | COVID-19 |
T16 | 544-552 | SP_7 | denotes | COVID-19 |
T17 | 583-592 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T18 | 888-893 | CHEBI:18059;CHEBI:18059;GO:0006629 | denotes | lipid |
T19 | 894-911 | GO:0006629 | denotes | metabolic process |
T20 | 913-932 | GO:0042592 | denotes | homeostatic process |
T21 | 956-963 | CHEBI:35341;CHEBI:35341;GO:0006694 | denotes | steroid |
T22 | 964-976 | GO:0006694 | denotes | biosynthesis |
T23 | 1115-1124 | UBERON:0002048 | denotes | pulmonary |
T77241 | 19-27 | SP_7 | denotes | COVID-19 |
T25522 | 71-76 | NCBITaxon:10239 | denotes | viral |
T26726 | 109-118 | GO:0008152 | denotes | metabolic |
T22563 | 221-229 | SP_7 | denotes | COVID-19 |
T45473 | 239-244 | NCBITaxon:10239 | denotes | viral |
T92290 | 250-263 | CHEBI:67079;CHEBI:67079 | denotes | -inflammatory |
T26450 | 268-277 | GO:0008152 | denotes | metabolic |
T9512 | 356-365 | SP_7 | denotes | 2019-nCov |
T7610 | 428-436 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 888-893 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 19-27 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 28-34 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T3 | 221-229 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 428-436 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 544-552 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 1064-1085 | Disease | denotes | inflammatory diseases | http://purl.obolibrary.org/obo/MONDO_0021166 |
T7 | 1087-1093 | Disease | denotes | asthma | http://purl.obolibrary.org/obo/MONDO_0004979 |
T8 | 1095-1132 | Disease | denotes | chronic obstructive pulmonary Disease | http://purl.obolibrary.org/obo/MONDO_0005002 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 96-104 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T2 | 166-167 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T3 | 480-481 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 514-517 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T5 | 576-582 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T6 | 878-886 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T7 | 983-992 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
T8 | 1016-1025 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 756-764 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
T2 | 888-893 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T3 | 956-963 | Chemical | denotes | steroid | http://purl.obolibrary.org/obo/CHEBI_35341 |
T4 | 1042-1045 | Chemical | denotes | TTD | http://purl.obolibrary.org/obo/CHEBI_73659 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 1087-1093 | Phenotype | denotes | asthma | http://purl.obolibrary.org/obo/HP_0002099 |
T2 | 1095-1132 | Phenotype | denotes | chronic obstructive pulmonary Disease | http://purl.obolibrary.org/obo/HP_0006510 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 878-911 | http://purl.obolibrary.org/obo/GO_0045834 | denotes | activity, lipid metabolic process |
T2 | 888-911 | http://purl.obolibrary.org/obo/GO_0006629 | denotes | lipid metabolic process |
T3 | 894-911 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolic process |
T4 | 913-932 | http://purl.obolibrary.org/obo/GO_0042592 | denotes | homeostatic process |
T5 | 956-976 | http://purl.obolibrary.org/obo/GO_0006694 | denotes | steroid biosynthesis |
T6 | 964-976 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | biosynthesis |
T7 | 978-1000 | http://purl.obolibrary.org/obo/GO_0035357 | denotes | PPAR signaling pathway |
T8 | 983-1000 | http://purl.obolibrary.org/obo/GO_0007165 | denotes | signaling pathway |
T9 | 983-992 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
T10 | 1002-1033 | http://purl.obolibrary.org/obo/GO_0033211 | denotes | adipocytokine signaling pathway |
T11 | 1002-1033 | http://purl.obolibrary.org/obo/GO_0033210 | denotes | adipocytokine signaling pathway |
T12 | 1002-1033 | http://purl.obolibrary.org/obo/GO_0033209 | denotes | adipocytokine signaling pathway |
T13 | 1016-1033 | http://purl.obolibrary.org/obo/GO_0007165 | denotes | signaling pathway |
T14 | 1016-1025 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-130 | Sentence | denotes | Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming |
T2 | 132-150 | Sentence | denotes | Graphical abstract |
T3 | 152-162 | Sentence | denotes | Highlights |
T4 | 163-205 | Sentence | denotes | • A novel FUNP analysis on QFPD function. |
T5 | 206-290 | Sentence | denotes | • QFPD act on COVID-19 via anti-viral, anti-inflammatory and metabolic programming. |
T6 | 291-366 | Sentence | denotes | • 9 QFPD ingredients presented good molecular docking score for 2019-nCov. |
T7 | 367-437 | Sentence | denotes | • SGMH, MXSG and Others are the top 3 efficient formula for COVID-19. |
T8 | 439-447 | Sentence | denotes | Abstract |
T9 | 448-562 | Sentence | denotes | Qingfei Paidu decoction (QFPD), a multi-component herbal formula, has been widely used to treat COVID-19 in China. |
T10 | 563-636 | Sentence | denotes | However, its active compounds and mechanisms of action are still unknown. |
T11 | 637-765 | Sentence | denotes | Firstly, we divided QFPD into five functional units (FUs) according to the compatibility theory of traditional Chinese medicine. |